Healthy adults
Conditions
Interventions
Questionnaire - saliva sampling - presenting control sample - saliva sampling - presenting control sample - measuring autonomic nervous system - presenting test sampling - measuring autonomic nervou
Sponsors
CPCC Company Limited
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Females aged 20 to 39 years old when consent obtain. 2) Females who show understanding of the clinical study procedures and agreement with participating the study by written informed consent prior to the study.
Exclusion criteria
Exclusion criteria: 1) Females who dislike the fragrance of black tea 2) Females who have smoking habit. 3) Females who are cold-sensitive constitution. 4) Females who are receiving medication due to treatment of some disease within current one month before the test. 5) Females who are receiving treatment for pollen allergy within current one month before the test. 6) Females with stuffy nose such as allergic rhinitis or females who can't identify the fragrance. 7) Subjects who have previous and/or current medical history of serious disease in liver, kidney, heart, lung and/or blood. 8) Females with high blood pressure symptoms such as systolic blood pressure of 160 mmHg and more or diastolic blood pressure of 100 mmHg and more. 9) Females who are pregnant or are lactating. 10) Females who have symptom of dermatologic disease such as atopic dermatitis. 11) Females who have undergone surgery on investigation objective portion within the past 6 months. 12) Females who are being treated by dentist, or females who plan to go dentist for receiving treatment. 13) Females who are participating the other clinical tests of medicines or foods. Females who participated other clinical tests of medicines or foods within a month prior to the current study. 14) Others who have been determined ineligible by principal investigator or sub-investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| *Evaluation of autonomic nervous system (pupil versus light reflection, skin temperature) * Evaluation of central nervous system (NIRS) | — |
Secondary
| Measure | Time frame |
|---|---|
| * Salivary substances (Chromogranin A, Oxytocin) *Multiple mood scale (short version, 40 question) *VAS questionnaire about fragrance and mood * Incidence of adverse events and side effects | — |
Countries
Japan
Contacts
Public ContactMasanori Numa
CPCC Company Limited Planning & Sales Department
Outcome results
None listed